We demonstrate that increased expression of RUNX3 and SMAD4 in tumor epithelial and stromal compartments and IRS-1 in stroma are independent predictors of a favorable prognosis in this patient group (Table 1 and Table 2 and Figure 3). The gene discussed is RUNX3; the disease is neoplasm.